BF Biosciences Limited (KASE: BFBIO)
Health Care · Pharmaceuticals · PK
PKRs124.18
-0.40% today · -16.5% 1Y
BF Biosciences Limited (KASE: BFBIO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $39.61M.
Over the last twelve months the share price has lost 16.5%, trading between 117.20 and 177.99.
Tweenvest scores BF Biosciences Limited across four factors: quality 79/100, value 76/100. Its strongest factor is quality.
BFBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.61M
- Revenue (TTM)
- $34.03M
- P/E
- 17.34
- EPS
- 7.16
- Dividend yield
- —
- Beta (5Y)
- -0.21
- 52-week high
- PKRs177.99
- 52-week low
- PKRs117.20
- Avg volume (3M)
- —
- Shares outstanding
- 88.33M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nasus Pharma Ltd.NYSEAM: NSRX | $41.12M | $3.33 | -5.13% |
| Hwail Pharmaceutical Co.,Ltd.KOSDAQ: A061250 | $40.68M | ₩6,500.00 | +2.36% |
| SCYNEXIS, Inc.NasdaqCM: SCYX | $40.59M | $4.08 | -0.12% |
| Herantis Pharma OyjHLSE: HRTIS | $39.83M | €1.34 | -5.36% |
| Filana Therapeutics, Inc.NasdaqCM: FLNA | $39.46M | $0.78 | -4.02% |
| Incannex Healthcare Inc.NasdaqCM: IXHL | $38.89M | $3.03 | -2.26% |
| Rekah Pharmaceutical Industry Ltd.TASE: REKA | $38.83M | ₪10.42 | -11.39% |
| Jin Yang Pharmaceutical Co., Ltd.KOSDAQ: A007370 | $38.36M | ₩3,995.00 | +0.50% |
Figures last refreshed Oct 11, 2026.